Health and Fitness Health and Fitness
Mon, June 14, 2010
[ 02:00 PM ] - Market Wire
Novartis, Biogen Idec, Teva, Apache and Devon Energy
[ 01:30 PM ] - Market Wire
Tenet Raises Outlook for 2010 Adjusted EBITDA by $50 Million
[ 01:05 PM ] - Market Wire
DexCom To Present at the William Blair & Company 30th Annual Growth Stock Conference
[ 01:01 PM ] - Market Wire
AtriCurea?s AtriClipa" System Receives FDA 510(k) Clearance
[ 11:15 AM ] - Market Wire
AGA Medical to Present at the Wells Fargo Securities Healthcare Conference on June 23, 2010
[ 11:11 AM ] - Market Wire
Aeterna Zentaris to Present Poster on Pharmacolog .. n Oral Synthetic Growth Hormone Secretagogue/Ghre
[ 09:51 AM ] - Market Wire
Finkelstein Thompson LLP Announces Investigation of Amedisys, Inc.
[ 09:30 AM ] - Market Wire
Orthovita to Present at the Wells Fargo Securities Healthcare Conference
[ 08:54 AM ] - Market Wire
Clinical Data, Inc. Announces Closing of $32.0 Mi .. ffering Including Full Exercise of Over-Allotment
[ 08:20 AM ] - Market Wire
PPD een van de beste CROa?s van Europa in 2010
[ 08:16 AM ] - Market Wire
PPD annoverata tra le migliori organizzazioni di ricerca a contratto (CRO) da?Europa nel 2010
[ 07:52 AM ] - Market Wire
PPD ist eins der fhrenden Auftragsforschungsinstitute des Jahres 2010 in Europa
[ 07:42 AM ] - Market Wire
Curis Announces Change to Presentation Time at Th .. itya?s Mid Year Check-up on Healthcare Conference
[ 06:42 AM ] - Market Wire
NewCardio Selected to Make Presentations at 32nd .. ce of the IEEE Engineering in Medicine and Biolog
[ 06:00 AM ] - Market Wire
Bristol-Myers Squibb Signs Agreements with ICON a .. port Greater Efficiencies in Clinical Development
[ 06:00 AM ] - Market Wire
Proxy Advisory Groups Recommend Shareholders of P .. te on Tang Capital and Perceptivea?s GOLD Proxy C
[ 05:35 AM ] - Market Wire
ZIOPHARM Set to Join Russell 3000® Index
[ 05:30 AM ] - Market Wire
CytRx Set to Join the Russell 3000 Index
[ 05:00 AM ] - Market Wire
Peregrine Set to Join Russell 3000
[ 04:32 AM ] - Market Wire
Resultados actualizados del estudio Fase III dond .. inuo con REVLIMID® en pacientes recientemente di
[ 04:31 AM ] - Market Wire
Presentazione di risultati aggiornati dello Studi .. ne del trattamento continuo con REVLIMID® in paz
[ 04:31 AM ] - Market Wire
Aktualisierte Ergebnisse von Phase-III-Studie ber .. diagnostiziertem multiplem Myelom mit REVLIMID®
[ 04:30 AM ] - Market Wire
Mise jour des r©sultats de la?©tude de phaseIII .. ompu au REVLIMID® de patients r©cemment diagnos
[ 04:30 AM ] - Market Wire
Charles River to Present at Goldman Sachs and William Blair Conferences
[ 03:30 AM ] - Market Wire
Human Genome Sciences Announces Preliminary Feedb .. From FDA on ZALBINa" BLA for Chronic Hepatitis C
[ 03:00 AM ] - Market Wire
New Autism Drug Research by Cellceutix on Compoun .. nt Behavioral Changes; Chief Scientific Officer S
Sat, June 12, 2010
[ 08:10 AM ] - Market Wire
Updated Results of Phase III Study Evaluating Con .. MID® Therapy in Newly Diagnosed Multiple Myeloma
[ 07:44 AM ] - Market Wire
Dr. Reddya?s provides update on the fexofenadine- .. oephedrine 24 hour Preliminary Injunction hearing
Fri, June 11, 2010
[ 06:00 PM ] - Market Wire
Law Offices of Howard G. Smith Announces Investig .. Shareholders of IPC The Hospitalist Company, Inc.
[ 03:27 PM ] - Market Wire
Fortune River Retains First Canadian Capital Corp. for Investor Relations Services

Fortune River Retains First Canadian Capital Corp. for Investor Relations Services


Published on 2010-06-11 15:40:10 - Market Wire
  Print publication without navigation


VANCOUVER, BRITISH COLUMBIA--(Marketwire - June 11, 2010) - Fortune River Resource Corp. (TSX VENTURE:FRX)(FRANKFURT:RG7A) ("Fortune") has retained First Canadian Capital Corp. ("First Canadian") as an investor relations and corporate communications consultant. First Canadian is based in Toronto and has provided corporate communications, investor relations and market awareness services to micro-cap, small cap and mid-cap public companies listed on North American stock exchanges for over ten years. First Canadian will aim to raise investor awareness, attract investment, and find strategic financial partners for Fortune.

The consulting agreement between Fortune and First Canadian has a term of 12 months, unless terminated earlier as provided in the agreement, and provides for a monthly fee of $3,500 to First Canadian. First Canadian's engagement as an investor relations consultant of Fortune is subject to regulatory approval of the TSX Venture Exchange.

On behalf of the Board of Directors

Joseph A. Kizis, Jr., President and Director

Fortune River Resource Corp.


Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contributing Sources